Fulgent Genetics Stock Options
| FLGT Stock | USD 20.74 0.10 0.48% |
Fulgent Genetics' option chain provides insight into all available option contracts written on Fulgent Genetics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Fulgent Genetics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Fulgent option contract.
In The Money vs. Out of Money Option Contracts on Fulgent Genetics
Analyzing Fulgent Genetics' in-the-money options over time can help investors to take a profitable long position in Fulgent Genetics regardless of its overall volatility. This is especially true when Fulgent Genetics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Fulgent Genetics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Fulgent Genetics' stock while costing only a fraction of its price.
Fulgent Genetics' latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 64.14 with a put-to-call open interest ratio of 0.25 over 14 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 2, with calls trading at the volume of 21. This yields a 0.1 put-to-call volume ratio. The Fulgent Genetics option chain provides detailed quote and price information for the current Fulgent Genetics option contracts. It shows all of Fulgent Genetics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
Fulgent Genetics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Fulgent Genetics' lending market. For example, when Fulgent Genetics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Fulgent Genetics, he or she must hedge the risk by shorting Fulgent Genetics stock over its option's life.
2024-05-17
The chart above shows Fulgent Genetics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Fulgent Genetics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Fulgent Genetics' option, there is no secondary market available for investors to trade.
Fulgent Genetics Maximum Pain Price across 2024-05-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Fulgent Genetics close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Fulgent Genetics' stock options are financial instruments that give investors the right to buy or sell shares of Fulgent Genetics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Fulgent stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Fulgent Genetics' stock price goes up or down, the stock options follow.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Please note that buying 'in-the-money' options on Fulgent Genetics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Fulgent Genetics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Fulgent Genetics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Fulgent Stock moves the wrong way.
At this time, Fulgent Genetics' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 1.3 B in 2024, whereas Common Stock Total Equity is likely to drop 2,565 in 2024. Fulgent Genetics In The Money Call Balance
When Fulgent Genetics' strike price is surpassing the current stock price, the option contract against Fulgent Genetics stock is said to be in the money. When it comes to buying Fulgent Genetics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Fulgent Genetics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Fulgent Current Options Market Mood
Fulgent Genetics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Fulgent Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Fulgent Genetics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Fulgent Genetics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Fulgent Genetics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Fulgent contract
Base on the Rule 16, the options market is currently suggesting that Fulgent Genetics will have an average daily up or down price movement of about 4.01% per day over the life of the 2024-05-17 option contract. With Fulgent Genetics trading at USD 20.74, that is roughly USD 0.83. If you think that the market is fully incorporating Fulgent Genetics' daily price movement you should consider buying Fulgent Genetics options at the current volatility level of 64.14%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Fulgent |
Purchasing Fulgent Genetics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Fulgent calls. Remember, the seller must deliver Fulgent Genetics stock to the call owner when a call is exercised.
Fulgent Genetics Option Chain
When Fulgent Genetics' strike price is surpassing the current stock price, the option contract against Fulgent Genetics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Fulgent Genetics' option chain is a display of a range of information that helps investors for ways to trade options on Fulgent. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Fulgent. It also shows strike prices and maturity days for a Fulgent Genetics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $12.5 | 0.8847 | 0.0173 | 0 | 2024-05-17 | 7.6 - 10.4 | 0.0 | In |
Call | 2024-05-17 CALL at $15.0 | 0.8479 | 0.0295 | 0 | 2024-05-17 | 5.1 - 7.8 | 0.0 | In |
Call | 2024-05-17 CALL at $17.5 | 0.8519 | 0.0636 | 1 | 2024-05-17 | 3.4 - 3.6 | 3.22 | In |
Call | 2024-05-17 CALL at $20.0 | 0.6143 | 0.1095 | 23 | 2024-05-17 | 1.6 - 1.8 | 1.75 | In |
Call | 2024-05-17 CALL at $22.5 | 0.3286 | 0.1105 | 286 | 2024-05-17 | 0.5 - 0.65 | 0.65 | Out |
Call | 2024-05-17 CALL at $25.0 | 0.1313 | 0.0657 | 132 | 2024-05-17 | 0.1 - 0.2 | 0.2 | Out |
Put | 2024-05-17 PUT at $17.5 | -0.148 | 0.0638 | 13 | 2024-05-17 | 0.25 - 0.35 | 0.35 | Out |
Put | 2024-05-17 PUT at $20.0 | -0.3834 | 0.1182 | 96 | 2024-05-17 | 0.9 - 1.0 | 0.85 | Out |
Put | 2024-05-17 PUT at $22.5 | -0.7067 | 0.1218 | 3 | 2024-05-17 | 2.15 - 2.45 | 2.4 | In |
Put | 2024-05-17 PUT at $25.0 | -0.8232 | 0.068 | 0 | 2024-05-17 | 4.0 - 5.3 | 0.0 | In |
Put | 2024-05-17 PUT at $30.0 | -0.9334 | 0.0273 | 0 | 2024-05-17 | 8.9 - 10.0 | 0.0 | In |
Fulgent Genetics Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Fulgent Genetics Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Fulgent Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fulgent Genetics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Fulgent Genetics Corporate Directors
Fulgent Genetics corporate directors refer to members of a Fulgent Genetics board of directors. The board of directors generally takes responsibility for the Fulgent Genetics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Fulgent Genetics' board members must vote for the resolution. The Fulgent Genetics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| James Mulay | Director | Profile | |
| Linda Marsh | Director | Profile | |
| John Bolger | Director | Profile | |
| Hanlin Gao | Lab Director and Chief Scientific Officer | Profile |
Already Invested in Fulgent Genetics?
The danger of trading Fulgent Genetics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Fulgent Genetics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Fulgent Genetics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Fulgent Genetics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Fulgent Genetics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Fulgent Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Fulgent Genetics Stock. Highlighted below are key reports to facilitate an investment decision about Fulgent Genetics Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.Note that the Fulgent Genetics information on this page should be used as a complementary analysis to other Fulgent Genetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Fulgent Stock analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Fulgent Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fulgent Genetics. If investors know Fulgent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fulgent Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share (5.63) | Revenue Per Share 9.71 | Quarterly Revenue Growth 0.041 | Return On Assets (0.03) |
The market value of Fulgent Genetics is measured differently than its book value, which is the value of Fulgent that is recorded on the company's balance sheet. Investors also form their own opinion of Fulgent Genetics' value that differs from its market value or its book value, called intrinsic value, which is Fulgent Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fulgent Genetics' market value can be influenced by many factors that don't directly affect Fulgent Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulgent Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulgent Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fulgent Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.